Real World Data Studies of Antineoplastic Drugs: How Can They Be Improved to Steer Everyday Use in the Clinic?

There is a growing interest in real world evidence when developing antineoplastic drugs owing to the shorter length of time and low costs compared to randomised controlled trials. External validity of studies in the regulatory phase can be enhanced by complementing randomised controlled trials with...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Gincy, Russell, Beth, Rigg, Anne, Coolen, Anthony C C, Van Hemelrijck, Mieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493103/
https://www.ncbi.nlm.nih.gov/pubmed/37701044
http://dx.doi.org/10.2147/POR.S395959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493103/
https://www.ncbi.nlm.nih.gov/pubmed/37701044
http://dx.doi.org/10.2147/POR.S395959

Ejemplares similares